Edited by the Technology and Proprietary Rights Group of Weil, Gotshal & Manges LLP
Intellectual Property Technology Law Journal
&
VOLUME 29 • NUMBER 9 • SEPTEMBER 2017 The Use of Genetic Evidence to Defend Against Toxic Tort Claims—Part I . . . . . . . . . . . . . . . . . . . . . 3
Toxic tort cases generally involve claims that an individual was harmed as a consequence of exposure to a chemical(s) (includ- ing a medication). These cases can be particularly diffi cult to litigate because of the challenges presented by demonstrating- r disproving causation. Because we do not fully understand
- unsatisfying. This multi-part article, by Susan E. Brice, a part-
- defendants. In this fi
FDA Amends Regulations for 505(b)(2) Applications and ANDAs—Part I . . . . . . . . . . . . . . . 11
This two-part article, by Shana K. Cyr, Li Feng, and Thomas L. Irving, patent attorneys at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, considers the U.S. Food and Drug Administration’s amendments to the regulations relating to the approval of new drugs. In this fi rst part of the article, the authors discuss the background of the regulations and certain- f the amendments that warrant consideration. The second
Trademark Rights Protection Mechanisms in the Domain Name System: Current Landscape and Efforts to Diminish Protection . . . . . . . . . . . . . 17
This article, by Brian J. Winterfeldt and Griffi n M. Barnett, attorneys at Mayer Brown LLP, presents an overview of these trademark Rights Protection Mechanisms (RPMs), key devel-- pments within the RPM review process and an analysis of
- pportunities and risks this review presents for brand owners,
When to Ask for Additional Discovery Can Be Just as Important as What to Ask for . . . . . . . . . 23
In Garmin Int’l, Inc. v. Cuozzo Speed Tech. LLC, the Patent Trial and Appeal Board (Board) set forth fi ve factors—commonly referred to as the Garmin factors—for determining whether “additional discovery” will be granted to a party during a proceeding before the Board, such as an inter partes review, covered business method review, or post-grant review. In their article, Nelson D. Runkle and Tyler Del Rosario, of Sughrue Mion, PLLC, discuss the fi ve factors and when to ask for addi- tional discovery.